Halozyme Therapeutics, Inc. (LON:0J2O)
57.93
+1.42 (2.52%)
At close: Feb 21, 2025
Halozyme Therapeutics Employees
Halozyme Therapeutics had 373 employees as of December 31, 2023. The number of employees decreased by 20 or -5.09% compared to the previous year.
Employees
373
Change (1Y)
-20
Growth (1Y)
-5.09%
Revenue / Employee
2.32M GBP
Profits / Employee
1.01M GBP
Market Cap
5.63B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Halozyme Therapeutics News
- 19 days ago - Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results - PRNewsWire
- 20 days ago - CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer - PRNewsWire
- 6 weeks ago - Halozyme raises 2025 guidance, announces $250M stock buyback - Seeking Alpha
- 6 weeks ago - Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance - PRNewsWire
- 6 weeks ago - Halozyme Therapeutics Inc (HALO) Announces Investor Conference Call for 2025 Financial Guidance - GuruFocus
- 6 weeks ago - Halozyme to Host Investor Conference Call to Provide Updated 2025 Financial Guidance - PRNewsWire
- 7 weeks ago - Halozyme: 'Accidental' Business Model Has Exciting Upside Opportunities In 2025 - Seeking Alpha
- 7 weeks ago - Halozyme: Recent Approvals Alter My Appetite - Seeking Alpha